Ascendis Pharma A/S (NASDAQ:ASND) Q1 2025 Earnings Call Transcript May 1, 2025
Ascendis Pharma A/S misses on earnings expectations. Reported EPS is $-1.79348 EPS, expectations were $-1.56.
Operator: Ladies and gentlemen, thank you for standing by and welcome to Ascendis Pharma First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be...
